Position in OCGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$47,217
+$17,569 QoQ
Shares Held
26,087
+18.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Creative Planning holds $339,978,470 across 212 Biotechnology names. OCGN ranks #188 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
109,524 | $48,906,846 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
40,152 | $31,023,041 | |
| 3 | INSM |
INSMED Inc
|
72,200 | $11,806,144 | |
| 4 | EXEL |
Exelixis, Inc.
|
234,142 | $10,042,350 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
119,661 | $8,886,025 | |
| 6 | PCVX |
Vaxcyte, Inc.
|
140,177 | $8,145,685 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
24,122 | $7,981,245 | |
| 8 | INCY |
Incyte Corp
|
80,874 | $7,611,860 |
All Filings in OCGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $47,217 | 26,087 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $29,648 | 21,962 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $30,458 | 18,686 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $57,332 | 59,106 | Shares | Defined | 2025-08-08 | |
| 2024-09-30 | $15,004 | 15,125 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $18,993 | 12,254 | Shares | Sole | 2024-08-15 | |
| 2023-03-31 | $11,153 | 13,076 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $18,743 | 14,418 | Shares | Sole | 2023-02-10 | |
| 2021-03-31 | $82,220 | 12,109 | Shares | Sole | 2021-04-30 | |
| No filing history on record for this holder in this stock. | ||||||